rs2498834
Variant names:
Your query was ambiguous. Multiple possible variants found:
Variant summary
Our verdict is Benign. The variant received -12 ACMG points: 0P and 12B. BP4_StrongBA1
The NM_006329.4(FBLN5):c.380-9430T>G variant causes a intron change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.739 in 152,180 control chromosomes in the GnomAD database, including 42,423 homozygotes. In-silico tool predicts a benign outcome for this variant. No clinical diagnostic laboratories have submitted clinical-significance assessments for this variant to ClinVar.
Frequency
Genomes: 𝑓 0.74 ( 42423 hom., cov: 33)
Consequence
FBLN5
NM_006329.4 intron
NM_006329.4 intron
Scores
2
Clinical Significance
Not reported in ClinVar
Conservation
PhyloP100: -1.59
Publications
3 publications found
Genes affected
FBLN5 (HGNC:3602): (fibulin 5) The protein encoded by this gene is a secreted, extracellular matrix protein containing an Arg-Gly-Asp (RGD) motif and calcium-binding EGF-like domains. It promotes adhesion of endothelial cells through interaction of integrins and the RGD motif. It is prominently expressed in developing arteries but less so in adult vessels. However, its expression is reinduced in balloon-injured vessels and atherosclerotic lesions, notably in intimal vascular smooth muscle cells and endothelial cells. Therefore, the protein encoded by this gene may play a role in vascular development and remodeling. Defects in this gene are a cause of autosomal dominant cutis laxa, autosomal recessive cutis laxa type I (CL type I), and age-related macular degeneration type 3 (ARMD3). [provided by RefSeq, Jul 2008]
FBLN5 Gene-Disease associations (from GenCC):
- cutis laxa, autosomal dominant 2Inheritance: AD Classification: DEFINITIVE, STRONG Submitted by: G2P, Genomics England PanelApp
- cutis laxa, autosomal recessive, type 1AInheritance: SD, AR Classification: DEFINITIVE, STRONG, MODERATE Submitted by: Ambry Genetics, Genomics England PanelApp, G2P, Labcorp Genetics (formerly Invitae), PanelApp Australia
- Charcot-Marie-Tooth disease, demyelinating, IIA 1HInheritance: AD Classification: STRONG Submitted by: Labcorp Genetics (formerly Invitae)
- demyelinating hereditary motor and sensory neuropathyInheritance: AD Classification: MODERATE Submitted by: ClinGen
- macular degeneration, age-related, 3Inheritance: AD Classification: MODERATE Submitted by: Ambry Genetics
- autosomal dominant cutis laxaInheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet
- hereditary sensorimotor neuropathy with hyperelastic skinInheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet
- autosomal recessive cutis laxa type 1Inheritance: AR Classification: SUPPORTIVE Submitted by: Orphanet
Genome browser will be placed here
ACMG classification
Classification was made for transcript
Our verdict: Benign. The variant received -12 ACMG points.
BP4
Computational evidence support a benign effect (BayesDel_noAF=-1.01).
BA1
GnomAd4 highest subpopulation (AMR) allele frequency at 95% confidence interval = 0.825 is higher than 0.05.
Transcripts
RefSeq
| Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | MANE | Protein | UniProt |
|---|---|---|---|---|---|---|---|---|
| FBLN5 | NM_006329.4 | c.380-9430T>G | intron_variant | Intron 4 of 10 | ENST00000342058.9 | NP_006320.2 |
Ensembl
Frequencies
GnomAD3 genomes AF: 0.739 AC: 112437AN: 152062Hom.: 42406 Cov.: 33 show subpopulations
GnomAD3 genomes
AF:
AC:
112437
AN:
152062
Hom.:
Cov.:
33
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
We have no GnomAD4 exomes data on this position. Probably position not covered by the project.
GnomAD4 genome AF: 0.739 AC: 112516AN: 152180Hom.: 42423 Cov.: 33 AF XY: 0.743 AC XY: 55269AN XY: 74404 show subpopulations
GnomAD4 genome
AF:
AC:
112516
AN:
152180
Hom.:
Cov.:
33
AF XY:
AC XY:
55269
AN XY:
74404
show subpopulations
African (AFR)
AF:
AC:
24547
AN:
41492
American (AMR)
AF:
AC:
12808
AN:
15292
Ashkenazi Jewish (ASJ)
AF:
AC:
2670
AN:
3468
East Asian (EAS)
AF:
AC:
3538
AN:
5172
South Asian (SAS)
AF:
AC:
3497
AN:
4822
European-Finnish (FIN)
AF:
AC:
9043
AN:
10614
Middle Eastern (MID)
AF:
AC:
219
AN:
292
European-Non Finnish (NFE)
AF:
AC:
53850
AN:
68004
Other (OTH)
AF:
AC:
1599
AN:
2112
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.506
Heterozygous variant carriers
0
1485
2971
4456
5942
7427
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance
Age Distribution
Genome Het
Genome Hom
Variant carriers
0
846
1692
2538
3384
4230
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
Hom.:
Bravo
AF:
Asia WGS
AF:
AC:
2417
AN:
3478
ClinVar
Not reported inComputational scores
Source:
Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
DANN
Benign
PhyloP100
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at
Publications
You must be logged in to view publications. This limit was set because tens of millions (!) of queries from AI bots are generated daily.